| NCT ID | NCT05620329 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UNC Lineberger Comprehensive Cancer Center |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 9,999 participants |
| Start Date | 2018-01-24 |
| Primary Completion | 2050-01-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 9,999 participants in total. It began in 2018-01-24 with a primary completion date of 2050-01-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Research with biospecimens such as blood, tissue, or body fluids can help researchers understand how the human body works. Researchers can make new tests to find diseases, understand how treatments work, or find new ways to treat a disease. The purpose of this study is to collect biospecimens for research from patients with known or suspected lung cancer. The information learned from the biospecimens may be used in future treatments. The purpose of this protocol is to create a pleural fluid registry for use in future studies.
Eligibility Criteria
Inclusion Criteria: * Patients who are 18 years or older * Inpatients and outpatients * Diagnosed with pleural fluid, are referred for and undergo clinically indicated drainage who have clinical evidence of: * pulmonary infection (such as fever, leukocytosis, new or worsening infiltrate on chest x-ray, or clinical deterioration) with effusion * malignancy Exclusion Criteria: * A subject will not be eligible for inclusion in this registry if, in the investigator's (or treating clinician's) opinion, the patient has any concurrent medical condition that may preclude their ability to undergo pleural fluid drainage safely. * Incarcerated individuals
Contact & Investigator
Jason Akulian
PRINCIPAL INVESTIGATOR
UNC Lineberger Comprehensive Cancer Center
Frequently Asked Questions
Who can join the NCT05620329 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05620329 currently recruiting?
Yes, NCT05620329 is actively recruiting participants. Contact the research team at carmmene@med.unc.edu for enrollment information.
Where is the NCT05620329 trial being conducted?
This trial is being conducted at Chapel Hill, United States.
Who is sponsoring the NCT05620329 clinical trial?
NCT05620329 is sponsored by UNC Lineberger Comprehensive Cancer Center. The principal investigator is Jason Akulian at UNC Lineberger Comprehensive Cancer Center. The trial plans to enroll 9,999 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.